The broad spectrum of tyrosine kinase inhibitors. Treatment of a rare EGFR R776H mutation with Osimertinib: Case report

Cui, JY; Tabbara, S; Chadha, J

Cui, JY (通讯作者),Univ S Florida, Morsani Sch Med, 560 Channelside Dr, Tampa, FL 33602 USA.

SAGE OPEN MEDICAL CASE REPORTS, 2023; 11 ():

Abstract

EGFR mutations comprise a sizeable portion of non-small cell lung cancers. While the most common EGFR mutation consists of exon 19 in-frame deletions ......

Full Text Link